"There's clear evidence that they [safe injection sites] address risky injection behaviours, and that they therefore could potentially lead to decreased complications like HIV and hepatitis infections, as well as abscesses and necroses," says Dr. Ahmed Bayoumi, an internist and researcher at the Centre for Research on Inner City Health at St. Michael's Hospital in Toronto, Ontario.
Bayoumi also coauthored the Report of the Toronto and Ottawa Supervised Consumption Assessment Study, 2012, which concluded Toronto could benefit from three supervised injection facilities and Ottawa from two.
A new study by the British Columbia Centre for Excellence in HIV/AIDS supports Tyndall and Bayoumi's claims for the health benefits of safe injection sites. The study indicates Vancouver's harm reduction strategy, including the InSite location, has reduced illicit drug use, improved public safety and reduced new HIV and hepatitis C infections.
There is also good evidence that the centre facilitates entrance into treatment programs for people who are ready to quit using, says Bayoumi.
"This is not legislation that's really focused on health at all," he says of the Respect for Communities Act. "The Supreme Court was clear that the health concerns had to be considered relative to the community concerns. What this legislation does is focus only on those community concerns."
The legislation would require applicants to submit the views of local law enforcement, municipal leaders, public health officials and provincial and territorial ministers of health. They would also have to provide information about the expected impact on local crime rates, data on drug use in the community, treatment options, evidence of sufficient resources to sustain the site and public health reasons for operating it, among other documentation.
The Canadian Medical Association is concerned that these requirements "may be creating unnecessary obstacles and burdens that could ultimately deter creation of more injection sites," it said in a statement. Harm reduction tools, including supervised injection sites, should be part of a national drug strategy, the CMA said.
"The CMA's position is founded upon clinical evidence. Bill C-65, it would appear, is founded upon ideology that seeks to hinder initiatives to mitigate the very real challenges and great personal harm caused by drug abuse," the statement added.
Despite the obstacles, community organizations in Ottawa, Toronto and Montréal, Quebec, will likely submit applications to test the new legislation if it is passed, says Tyndall. "We still want to position this as a health intervention in communities that are in a desperate state." -Laura Eggertson, CMAJ
